Saudi Arabia's Dallah Healthcare has finalized a significant deal to acquire stakes in two healthcare firms, following its earlier MoUs this year. The company entered into a binding share purchase and subscription agreement with Ayyan Investment Co., committing to acquire shares in Al Ahsa Medical Services Co. and Al Salam Medical Services Co. for around 660 million riyals ($176 million). This acquisition will be executed through a capital increase, with Dallah issuing new shares to Ayyan Investment as part of the transaction.

Dallah Healthcare, focused on expanding its presence and enhancing medical services across the kingdom, will gain a 97.41% shareholding in Al Ahsa Medical Services and 100% in Al Salam Medical Services. The agreed net market value for Al Ahsa's equity is SAR 420 million, with the valuation for Dallah's acquisition share being approximately SAR 409 million. Al Salam's full acquisition is valued at about SAR 250.88 million. The transaction values Dallah at SAR 16.56 billion, based on an average share price from February to August. Post-transaction, Dallah's capital will increase by 3.99%, resulting in a slight decrease in the ownership percentage of existing shareholders to 96.17%.